DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Etzerodt A, Tsalkitzi K, Maniecki M. et al.
Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.
J Exp Med 2019;
216 (10) 2394-2411
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.